189 related articles for article (PubMed ID: 16019555)
1. Malignant pleural effusions in lymphoproliferative disorders.
Ahmed S; Shahid RK; Rimawi R; Siddiqui AK; Rossoff L; Sison CP; Steinberg H; Rai KR
Leuk Lymphoma; 2005 Jul; 46(7):1039-44. PubMed ID: 16019555
[TBL] [Abstract][Full Text] [Related]
2. Identifying Malignant Pleural Effusion by A Cancer Ratio (Serum LDH: Pleural Fluid ADA Ratio).
Verma A; Abisheganaden J; Light RW
Lung; 2016 Feb; 194(1):147-53. PubMed ID: 26678281
[TBL] [Abstract][Full Text] [Related]
3. Differentiating Malignant from Tubercular Pleural Effusion by Cancer Ratio Plus (Cancer Ratio: Pleural Lymphocyte Count).
Verma A; Dagaonkar RS; Marshall D; Abisheganaden J; Light RW
Can Respir J; 2016; 2016():7348239. PubMed ID: 28070157
[No Abstract] [Full Text] [Related]
4. Detection of Pleural Fluid Biochemistry Changes in Two Consecutive Thoracenteses for Differentiating Malignant from Benign Effusions.
Bielsa S; García-Zamalloa A; Monteagudo P; González-Sans D; Ascanio D; Esquerda A; Taboada-Gómez J; Porcel JM
Arch Bronconeumol (Engl Ed); 2018 Jun; 54(6):320-326. PubMed ID: 29496288
[TBL] [Abstract][Full Text] [Related]
5. Pleural fluid findings as prognostic factors for malignant pleural mesothelioma.
Gonlugur TE; Gonlugur U
J Clin Lab Anal; 2008; 22(5):334-6. PubMed ID: 18803276
[TBL] [Abstract][Full Text] [Related]
6. Predicting malignant and tuberculous pleural effusions through demographics and pleural fluid analysis of patients.
Valdés L; San-José E; Ferreiro L; Golpe A; González-Barcala FJ; Toubes ME; Rodríguez-Álvarez MX; Álvarez-Dobaño JM; Rodríguez-Núñez N; Rábade C; Gude F
Clin Respir J; 2015 Apr; 9(2):203-13. PubMed ID: 25849297
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of a new score using serum alkaline phosphatase and pleural effusion lactate dehydrogenase for patients with malignant pleural effusion.
Shi XY; Yi FS; Wang Z; Qiao X; Zhai K
Thorac Cancer; 2020 Feb; 11(2):320-328. PubMed ID: 31837116
[TBL] [Abstract][Full Text] [Related]
8. [Pleural effusions--experience of Pneumo-phtisiology Hospital Tudor Vladimirescu--I: Clinical study].
Olaru M; Pleşea IE; Mălăescu D; Olaru R
Pneumologia; 2008; 57(3):138-46. PubMed ID: 18998326
[TBL] [Abstract][Full Text] [Related]
9. Breast and Lung Effusion Survival Score Models: Improving Survival Prediction in Patients With Malignant Pleural Effusion and Metastasis.
Molina S; Martinez-Zayas G; Sainz PV; Leung CH; Li L; Grosu HB; Adachi R; Ost DE
Chest; 2021 Sep; 160(3):1075-1094. PubMed ID: 33852918
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor in pleural fluid for differential diagnosis of benign and malignant origin and its clinical applications.
Fiorelli A; Vicidomini G; Di Domenico M; Napolitano F; Messina G; Morgillo F; Ciardiello F; Santini M
Interact Cardiovasc Thorac Surg; 2011 Mar; 12(3):420-4. PubMed ID: 21172937
[TBL] [Abstract][Full Text] [Related]
11. Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters.
Herrera Lara S; Fernández-Fabrellas E; Juan Samper G; Marco Buades J; Andreu Lapiedra R; Pinilla Moreno A; Morales Suárez-Varela M
Lung; 2017 Oct; 195(5):653-660. PubMed ID: 28656381
[TBL] [Abstract][Full Text] [Related]
12. Cytologically proved malignant pleural effusions: distribution of transudates and exudates.
Assi Z; Caruso JL; Herndon J; Patz EF
Chest; 1998 May; 113(5):1302-4. PubMed ID: 9596310
[TBL] [Abstract][Full Text] [Related]
13. Pleural LDH as a prognostic marker in adenocarcinoma lung with malignant pleural effusion.
Verma A; Phua CK; Sim WY; Algoso RE; Tee KS; Lew SJ; Lim AY; Goh SK; Tai DY; Kor AC; Ho B; Abisheganaden J
Medicine (Baltimore); 2016 Jun; 95(26):e3996. PubMed ID: 27368006
[TBL] [Abstract][Full Text] [Related]
14. Differentiating tuberculous from malignant pleural effusions: a scoring model.
Porcel JM; Vives M
Med Sci Monit; 2003 May; 9(5):CR175-80. PubMed ID: 12761453
[TBL] [Abstract][Full Text] [Related]
15. [Differential diagnosis between exudate and transudate in pleural effusion].
Vázquez F; Michelángelo H; Trevisani H; González F; de Quiros B
Medicina (B Aires); 1996; 56(3):223-30. PubMed ID: 9035477
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine: new tumor marker in pleural fluid.
Santotoribio JD; Cañavate-Solano C; Garcia-de la Torre A; Del Valle-Vazquez L; Arce-Matute F; Cuadros-Muñoz JF; Sanchez del Pino MJ; Bandez-Ruiz MJ; Piñuela-Rojas C; Perez-Ramos S
Tumour Biol; 2015 Sep; 36(10):7941-5. PubMed ID: 25956279
[TBL] [Abstract][Full Text] [Related]
17. Pleural and serum markers for diagnosis of malignant pleural effusion.
Allama AM; Abou-Elela DH; Ibrahim IM
Asian Cardiovasc Thorac Ann; 2020 Nov; 28(9):560-565. PubMed ID: 32741198
[TBL] [Abstract][Full Text] [Related]
18. A minimum fluid volume of 75 mL is needed to ensure adequacy in a pleural effusion: a retrospective analysis of 2540 cases.
Rooper LM; Ali SZ; Olson MT
Cancer Cytopathol; 2014 Sep; 122(9):657-65. PubMed ID: 25060164
[TBL] [Abstract][Full Text] [Related]
19. A decision tree for differentiating tuberculous from malignant pleural effusions.
Porcel JM; Alemán C; Bielsa S; Sarrapio J; Fernández de Sevilla T; Esquerda A
Respir Med; 2008 Aug; 102(8):1159-64. PubMed ID: 18573650
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil-to-lymphocyte ratio in malignant pleural fluid: Prognostic significance.
Popowicz N; Cheah HM; Gregory C; Miranda A; Dick IM; Lee YCG; Creaney J
PLoS One; 2021; 16(4):e0250628. PubMed ID: 33901252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
